31.55
price down icon0.50%   -0.16
after-market 시간 외 거래: 31.50 -0.05 -0.16%
loading
전일 마감가:
$31.71
열려 있는:
$31.71
하루 거래량:
297.31K
Relative Volume:
0.55
시가총액:
$1.14B
수익:
$154.15M
순이익/손실:
$-33.58M
주가수익비율:
-32.86
EPS:
-0.96
순현금흐름:
$-20.74M
1주 성능:
+0.10%
1개월 성능:
+21.81%
6개월 성능:
-6.74%
1년 성능:
+45.79%
1일 변동 폭
Value
$31.36
$32.13
1주일 범위
Value
$29.71
$32.13
52주 변동 폭
Value
$20.36
$59.23

Harrow Inc Stock (HROW) Company Profile

Name
명칭
Harrow Inc
Name
전화
615.733.4731
Name
주소
1A BURTON HILLS BLVD, NASHVILLE, CA
Name
직원
382
Name
트위터
Name
다음 수익 날짜
2025-03-17
Name
최신 SEC 제출 서류
Name
HROW's Discussions on Twitter

HROW을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Drug Manufacturers - Specialty & Generic icon
HROW
Harrow Inc
31.55 1.14B 154.15M -33.58M -20.74M -0.96
Drug Manufacturers - Specialty & Generic icon
RGC
Regencell Bioscience Holdings Ltd
21.73 303.95B 0 -5.87M -767.30K -0.45
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
157.23 74.39B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.50 48.97B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.97 47.39B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
17.00 20.17B 16.54B -1.64B 749.00M -1.45

Harrow Inc Stock (HROW) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-06-12 개시 BTIG Research Buy
2025-06-10 개시 William Blair Outperform
2025-02-06 개시 H.C. Wainwright Buy
2024-12-04 재확인 B. Riley Securities Buy
2024-04-11 개시 Craig Hallum Buy
2022-09-08 재개 B. Riley Securities Buy
2021-10-14 재개 B. Riley Securities Buy
2021-09-24 개시 Aegis Capital Buy
2021-07-02 개시 Ladenburg Thalmann Buy
모두보기

Harrow Inc 주식(HROW)의 최신 뉴스

pulisher
Jun 18, 2025

HROW to Participate in Lake Street's Virtual Meeting on June 24 - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Harrow Appoints Mike Biega as Vice President of Investor Relations and Communications | HROW Stock News - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Harrow Appoints Mike Biega as Vice President of Investor Relations and Communications - Business Wire

Jun 18, 2025
pulisher
Jun 17, 2025

Opaleye Management Inc. Adjusts Holdings in Harrow Inc. - GuruFocus

Jun 17, 2025
pulisher
Jun 16, 2025

Harrow wins new Outperform at William Blair after licensing deal for pain drug - MSN

Jun 16, 2025
pulisher
Jun 12, 2025

HARROW HEALTH SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Harrow Health To Contact Him Directly To Discuss Their Options - The Globe and Mail

Jun 12, 2025
pulisher
Jun 12, 2025

BTIG Initiates Harrow at Buy With $62 Price Target - MarketScreener

Jun 12, 2025
pulisher
Jun 11, 2025

BTIG Initiates Coverage of Harrow (HROW) with Optimistic Outlook - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Harrow Inc. sees $923,827 in stock sales by major shareholder - Investing.com South Africa

Jun 11, 2025
pulisher
Jun 11, 2025

BTIG Initiates Coverage of Harrow (HROW) with Optimistic Outlook | HROW Stock News - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

William Blair Bullish On Harrow's High-Margin Branded Eye Drug Strategy - Benzinga

Jun 11, 2025
pulisher
Jun 10, 2025

HARROW HEALTH INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Harrow Health To Contact Him Directly To Discuss Their Options - The Globe and Mail

Jun 10, 2025
pulisher
Jun 10, 2025

Harrow acquires U.S. commercial rights to BYQLOVI from Formosa Pharmaceuticals - MSN

Jun 10, 2025
pulisher
Jun 10, 2025

Harrow (HROW) Gains Coverage with Outperform Rating Following Licensing Deal - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Harrow stock wins William Blair's new Outperform (HROW:NASDAQ) - Seeking Alpha

Jun 10, 2025
pulisher
Jun 10, 2025

Assessing Harrow: Insights From 4 Financial Analysts - Benzinga

Jun 10, 2025
pulisher
Jun 10, 2025

Lake Street Remains a Buy on Harrow Health (HROW) - The Globe and Mail

Jun 10, 2025
pulisher
Jun 10, 2025

William Blair Initiates Coverage on Harrow (HROW) with Outperfor - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

William Blair Initiates Coverage on Harrow With Outperform Rating - marketscreener.com

Jun 10, 2025
pulisher
Jun 10, 2025

William Blair Initiates Outperform Rating for Harrow (HROW) | HR - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

William Blair Initiates Outperform Rating for Harrow (HROW) | HROW Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 09, 2025

Harrow Acquires U.S. Commercial Rights to BYQLOVI™ (Clobetasol Propionate Ophthalmic Suspension) 0.05% from Formosa Pharmaceuticals - mx.advfn.com

Jun 09, 2025
pulisher
Jun 09, 2025

Harrow (HROW) Secures Exclusive U.S. Rights for New Ophthalmic S - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Harrow (HROW) Secures U.S. Rights to BYQLOVI - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Harrow Acquires US Commercial Rights for Byqlovi From Formosa Pharmaceuticals - marketscreener.com

Jun 09, 2025
pulisher
Jun 09, 2025

Harrow Acquires U.S. Commercial Rights To Byqlovi(TM) From Formosa Pharmaceuticals - marketscreener.com

Jun 09, 2025
pulisher
Jun 09, 2025

HROW Signs Licensing Agreement for Exclusive U.S. Rights to Byqlovi 0.05% | HROW Stock News - GuruFocus

Jun 09, 2025
pulisher
Jun 08, 2025

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 29,262 Shares of Harrow, Inc. (NASDAQ:HROW) - Defense World

Jun 08, 2025
pulisher
Jun 05, 2025

Harrow Inc (HROW) Shares Down 5.39% on Jun 5 - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Bank of America Corp DE Trims Stock Holdings in Harrow, Inc. (NASDAQ:HROW) - Defense World

Jun 05, 2025
pulisher
Jun 02, 2025

Millennium Management LLC Sells 101,671 Shares of Harrow, Inc. (NASDAQ:HROW) - Defense World

Jun 02, 2025
pulisher
May 31, 2025

B. Riley Issues Pessimistic Forecast for Harrow Earnings - Defense World

May 31, 2025
pulisher
May 30, 2025

Insiders Favor Harrow And 2 Other Leading Growth Companies - Yahoo Finance

May 30, 2025
pulisher
May 30, 2025

Harrow Inc (HROW) Shares Up 4.04% on May 30 - GuruFocus

May 30, 2025
pulisher
May 30, 2025

Obituary for Douglas "Doug" A. Harrow - Schaffer Funeral Home, Inc.

May 30, 2025
pulisher
May 28, 2025

Harrow: Epic Growth & Operating Leverage On Full Display (NASDAQ:HROW) - Seeking Alpha

May 28, 2025
pulisher
May 23, 2025

Harrow Inc (HROW) Stock Price Down 3.78% on May 22 - GuruFocus

May 23, 2025
pulisher
May 21, 2025

Deutsche Bank AG Has $3.63 Million Holdings in Harrow, Inc. (NASDAQ:HROW) - Defense World

May 21, 2025
pulisher
May 18, 2025

The Manufacturers Life Insurance Company Has $372,000 Holdings in Harrow, Inc. (NASDAQ:HROW) - Defense World

May 18, 2025
pulisher
May 16, 2025

Harrow Inc (HROW) Stock Price Up 8.35% on May 16 - GuruFocus

May 16, 2025
pulisher
May 15, 2025

Harrow Inc.: Opaleye management sells $150,055 in stock - Investing.com Australia

May 15, 2025
pulisher
May 14, 2025

Harrow Inc.: Opaleye management sells $150,055 in stock By Investing.com - Investing.com India

May 14, 2025
pulisher
May 14, 2025

Jim Cramer on Harrow, Inc. (HROW) – “Eye Care’s a Good Biz – If It Makes Money, Don’t Walk Away Pre-Breakout” - Insider Monkey

May 14, 2025
pulisher
May 14, 2025

Harrow to Present at Two Investor Conferences in May - Business Wire

May 14, 2025
pulisher
May 13, 2025

Jim Cramer Is 'OK' With Harrow, Recommends Buying This Energy Stock - Benzinga

May 13, 2025
pulisher
May 13, 2025

Harrow Health, Inc. (NASDAQ:HROW) Q1 2025 Earnings Call Transcript - Insider Monkey

May 13, 2025
pulisher
May 13, 2025

Harrow (HROW) Faces Price Target Cut Amid Q1 Earnings Miss | HRO - GuruFocus

May 13, 2025
pulisher
May 13, 2025

HROW Stock Price Target Raised to $60 by Analyst | HROW Stock Ne - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Price T Rowe Associates Inc. MD Buys 1,428 Shares of Harrow, Inc. (NASDAQ:HROW) - Defense World

May 13, 2025
pulisher
May 13, 2025

Harrow (NASDAQ:HROW) Price Target Raised to $60.00 at HC Wainwright - Defense World

May 13, 2025
pulisher
May 12, 2025

Where Harrow Stands With Analysts - Benzinga

May 12, 2025

Harrow Inc (HROW) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Harrow Inc 주식 (HROW) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Opaleye Management Inc.
10% Owner
Jun 09 '25
Sale
30.37
15,204
461,794
105,000
Opaleye Management Inc.
10% Owner
Jun 03 '25
Sale
30.04
3,000
90,116
122,000
Opaleye Management Inc.
10% Owner
Jun 04 '25
Sale
30.02
1,796
53,907
120,204
Opaleye Management Inc.
10% Owner
May 12 '25
Sale
25.90
10,000
258,959
130,000
Opaleye Management Inc.
10% Owner
May 13 '25
Sale
26.59
5,000
132,945
125,000
BOLL ANDREW R.
Chief Financial Officer
Apr 03 '25
Option Exercise
0.00
346,500
0
914,589
SAHAREK JOHN P.
CEO & President, ImprimisRx
Apr 03 '25
Option Exercise
0.00
277,200
0
576,863
BAUM MARK L
Chief Executive Officer
Apr 03 '25
Option Exercise
0.00
762,300
0
2,899,825
Opaleye Management Inc.
10% Owner
Mar 18 '25
Sale
30.01
5,000
150,055
140,000
Opaleye Management Inc.
10% Owner
Mar 18 '25
Sale
29.64
5,000
148,200
145,000
$13.76
price up icon 1.85%
$8.89
price down icon 0.67%
$127.78
price down icon 0.31%
$285.97
price down icon 1.37%
drug_manufacturers_specialty_generic RDY
$15.50
price down icon 0.58%
$17.00
price down icon 0.53%
자본화:     |  볼륨(24시간):